LINEAGE THERAP earnings per share and revenue

LCTX earnings per share for the last quarter are -0.07 ILS whereas the estimation was -0.15 ILS which accounts for 50.00% surprise. Company revenue for the same period amounts to 14.10 M ILS despite the estimated figure of 3.86 M ILS. Estimated earnings per share for the next quarter are -0.13 ILS, and revenue is expected to reach 5.22 M ILS. Also watch annual changes over time to get a bigger picture of LCTX earnings per share and revenue dynamics.